Catalyst Wire Dossier Catalyst Wire Dossier

U32

· Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for U32, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of U32 in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing